Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (957)	4/7/1999 3:24:00 PM
From: Scott	Read Replies (1) \| Respond to of 3202

Sounds like a good idea for a thread. The author of the article you linked to, Kate Murashige, is one of the most respected biotech patent attorneys around.

To: Mike McFarland who wrote (957)	4/7/1999 10:48:00 PM
From: LLCF	Read Replies (1) \| Respond to of 3202

April issue of "Red Herring" has a feature series of articles called "The future of Biotech". It's really a bit of a "puff" with separate 1-2 page descriptions of: 1.) "Beyond the Genome"- bioinformatics-mentions Oxford GlycoSciences & Cytokinetics 2.) "PostGenomic World" - outlines Cytokinetcs founders and business plan... also mentions INCY, HYSQ,Genset, MLNM 3.)"Keep your Genes on"- Article about the dangers of Gene Patenting including Q & A with economist, activist Jeremy Rifkin. Basically says Gene Patents are illegal... the "cannot patent discoveries in nature" arguement. 4.)Genetic Sequencing explained. 5.)Why investors have little interest in Cloning. All in all not that interesting... but puts some of these issues out in front of the public... positive piece (except for Rifkin) for biotech... DAK